
    Original Text: Performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale within 3 days prior to first dose of pembrolizumab
    Disease/Condition: ECOG Performance Status
    Procedure: none
    Drug: Pembrolizumab
    Biomarker: none
    Computable Rule: PS_ECOG == 0 OR PS_ECOG == 1

Criterion:
    Patients with histologically confirmed advanced non-small cell lung cancer (NSCLC) with progression after platinum-based chemotherapy

Output:
    Original Text: Patients with histologically confirmed advanced non-small cell lung cancer (NSCLC) with progression after platinum-based chemotherapy
    Disease/Condition: NSCLC, Advanced Non-Small Cell Lung Cancer, Histology, Progression After Platinum-Based Chemotherapy
    Procedure: none
    Drug: none
    Biomarker: none
    Computable Rule: NSCLC == True AND Histology == True